All Stories

  1. Letter by Badano et al Regarding Article, “Prognostic Value of Exercise Right Ventricular–Pulmonary Arterial Coupling in Primary Mitral Regurgitation”
  2. Right Ventricular Contractile Reserve in Heart Failure With Preserved Ejection Fraction
  3. Left atrial dysfunction in significant AR: A trigger for earlier intervention?
  4. Reply to “Transaortic Flow Rate and Risk Stratification in Moderate Aortic Stenosis”
  5. Assessment of Right Ventricular Function Prior to Transcatheter Tricuspid Valve Interventions
  6. Threshold Values of Vena Contracta Area for Grading Secondary Tricuspid Regurgitation and its Association with Outcomes
  7. Clinical Applications of Strain Echocardiography: A Clinical Consensus Statement From the American Society of Echocardiography Developed in Collaboration With the European Association of Cardiovascular Imaging of the European Society of Cardiology
  8. Hemodynamic‐Driven Staging of Heart Failure With Preserved Ejection Fraction Using Unsupervised Cluster Analysis
  9. Response by Caravita et al to the Letter Regarding Article, “Determinants of Right Heart Hemodynamic Derangement in Patients With and Without Tricuspid Regurgitation”
  10. Invasive Validation of Right Ventricular Stroke Volume and Tricuspid Regurgitant Volume Obtained from Three-dimensional Echocardiography
  11. Clinical characteristics, management and outcomes of enterococcal infective endocarditis: an ancillary study from the ESC-EORP EURO-ENDO registry
  12. Unraveling the Complex Geometry of the Right Ventricle. From Shape to Outcome
  13. Association of Moderate to Severe Tricuspid Regurgitation With Exercise Hemodynamics and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction: Multicenter Study
  14. Decoding right ventricular geometry: novel 3D echocardiography-derived global shape analysis across health and disease states
  15. Refining tricuspid regurgitation severity assessment with new corrected proximal isovelocity surface area threshold values
  16. The Need for Refined Effective Regurgitant Orifice Area Cutoff Values to Define Severe Tricuspid Regurgitation.
  17. The Last Decade in Tricuspid Regurgitation
  18. Evolving Paradigms in Quantifying Functional Tricuspid Regurgitation—The Doppler Shape Dimension
  19. Comparison of the Right Atrial Expansion Index with Inferior Vena Cava Assessment for Echocardiographic Estimation of the Right Atrial Pressure
  20. Reply to “Transaortic Flow Rate and Risk Stratification in Moderate Aortic Stenosis - From Ventricle to Vasculature”
  21. Insufficienza tricuspidale secondaria atriale: una valvulopatia sottostimata ma di crescente rilevanza clinica
  22. Left ventricular ejection fraction and benefit of tricuspid valve interventions – insights from the international TRIGISTRY
  23. Determinants of Right Heart Hemodynamic Derangement in Patients With and Without Tricuspid Regurgitation
  24. Transaortic Flow Rate and Risk Stratification in Moderate Aortic Stenosis
  25. Clinical Applications of Strain Echocardiography: A Clinical Consensus Statement From the American Society of Echocardiography Developed in Collaboration With the European Association of Cardiovascular Imaging of the European Society of Cardiology
  26. Left atrial remodeling trajectories in hypertrophic cardiomyopathy: Reframing prognostic assessment through a dynamic lens
  27. Sex-specific differences in right heart remodelling and patient outcomes in secondary tricuspid regurgitation
  28. Reply to “The Doppler Angle Effect Needs to Be Considered Wherever in the Heart the Proximal Isovelocity Surface Area Method Is Utilized”
  29. Mechanical Adaptation of the Right Ventricle to Secondary Tricuspid Regurgitation and Its Association With Patient Outcomes
  30. Association With Outcome of the Regurgitant-Volume Adjusted Right Ventricular Ejection Fraction in Secondary Tricuspid Regurgitation
  31. Right Ventricular Function and Outcomes Stratified by the Effective Regurgitant Orifice Area in Secondary Tricuspid Regurgitation
  32. Right ventricular reserve in cardiopulmonary disease: A simultaneous hemodynamic and three-dimensional echocardiographic study
  33. Echocardiographic Tissue Characterization Using Radiomics in Patients With Transthyretin-Related Cardiac Amyloidosis
  34. Vendor differences in 2D-speckle tracking global longitudinal strain: an update on a 10-year standardization effort
  35. Deep learning-enabled echocardiographic assessment of biventricular ejection fractions: the dual-task QUEST-EF model
  36. Minimally Invasive Mitral Valve Repair With New-Generation Annuloplasty Ring: Results From the International Prospective MANTRA Study
  37. Ecocardiografía avanzada y análisis de conglomerados para identificar fenogrupos de insuficiencia tricuspídea secundaria con diferente riesgo
  38. Association With Outcomes of Correcting the Proximal Isovelocity Surface Area Method to Quantitate Secondary Tricuspid Regurgitation
  39. Utility of the Ratio Between the Size of the Right Atrium and the Right Ventricle at End-Systole to Diagnose Atrial Secondary Tricuspid Regurgitation
  40. A novel staging system of cardiac damage in aortic stenosis based on multi-chamber myocardial deformation
  41. Unlocking the Potential of Three-Dimensional Echocardiography for Diagnosing Pulmonary Valve Diseases
  42. Three-Dimensional Transthoracic Echocardiography for Semiautomated Analysis of the Tricuspid Annulus: Validation and Normal Values
  43. Mitral valve repair with the semi-rigid Memo 4D annuloplasty ring: early clinical and echocardiographic outcomes from the MANTRA study
  44. Discrepancy in the Diagnosis of Heart Failure With Preserved Ejection Fraction Between Supine Versus Upright Exercise Hemodynamic Testing
  45. Advances in the Assessment of Patients With Tricuspid Regurgitation: A State-of-the-Art Review on the Echocardiographic Evaluation Before and After Tricuspid Valve Interventions
  46. Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE
  47. Assessing right atrial size in patients with tricuspid regurgitation: importance of the right ventricular-focused view
  48. Editorial: Advances in heart valve imaging
  49. Impact of new-onset atrial fibrillation on the incidence of tricuspid regurgitation: a call to attention
  50. Significant Disagreement Between Conventional Parameters and 3D Echocardiography-Derived Ejection Fraction in the Detection of Right Ventricular Systolic Dysfunction and Its Association With Outcomes
  51. Timing and Patient Position During Cuff Blood Pressure Measurement Affect Myocardial Work Parameters Measured by Echocardiography
  52. Arrhythmic Mitral Valve Prolapse Phenotype: An Unsupervised Machine Learning Analysis Using a Multicenter Cardiac MRI Registry
  53. Effects of tricuspid transcatheter edge-to-edge repair on tricuspid annulus diameter - Data from the TriValve registry
  54. Letter by Tomaselli et al Regarding Article, “Left Atrial Strain Predicts Subclinical Atrial Fibrillation Detected by Long-Term Continuous Monitoring in Elderly High-Risk Individuals”
  55. Make Right Heart Remodeling in Secondary Tricuspid Regurgitation as Simple as Possible, But Not Simpler
  56. Management of Isolated Tricuspid Regurgitation
  57. Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair
  58. Diagnostic Contexts of Echocardiographic Nonapical Window
  59. Right Atrial Remodeling and Outcome in Patients with Secondary Tricuspid Regurgitation
  60. Clinical Impact of the Volumetric Quantification of Ventricular Secondary Mitral Regurgitation by Three-Dimensional Echocardiography
  61. ECG/echo indexes in the diagnostic approach to amyloid cardiomyopathy: A head-to-head comparison from the AC-TIVE study
  62. Leaflet Coaptation Gaps in Severe Tricuspid Regurgitation: Unraveling the Morphological Challenges in the Tricuspid Transcatheter Edge-to-Edge Repair Landscape
  63. Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions
  64. Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment
  65. Peak atrial longitudinal strain and risk stratification in moderate and severe aortic stenosis
  66. The conundrum of the reference values of left atrial size and function
  67. Epidemiology, pathophysiology, diagnosis and management of chronic right‐sided heart failure and tricuspid regurgitation. A clinical consensus statement of the Heart Failure Association (HFA) and the European Association of Percutaneous Card...
  68. Tricuspid valve disease and cardiac implantable electronic devices
  69. Characteristics and outcomes of patients with atrial versus ventricular secondary tricuspid regurgitation undergoing tricuspid transcatheter edge‐to‐edge repair – Results from the TriValve registry
  70. Right atrial function, a mostly ignored but very valuable parameter in patients with secondary tricuspid regurgitation
  71. Clinical Value of a Novel Three-Dimensional Echocardiography–Derived Index of Right Ventricle–Pulmonary Artery Coupling in Tricuspid Regurgitation
  72. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
  73. Deep learning assisted measurement of echocardiographic left heart parameters: improvement in interobserver variability and workflow efficiency
  74. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
  75. Shedding Light on Latent Pulmonary Vascular Disease in Heart Failure With Preserved Ejection Fraction
  76. Tricuspid Valve Academic Research Consortium Definitions for Tricuspid Regurgitation and Trial Endpoints
  77. Incremental Value of Right Atrial Strain Analysis to Predict Atrial Fibrillation Recurrence After Electrical Cardioversion
  78. Right Heart Adaptation to Exercise in Pulmonary Hypertension: An Invasive Hemodynamic Study
  79. TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation
  80. Predictors of embolism and death in left-sided infective endocarditis: the European Society of Cardiology EURObservational Research Programme European Infective Endocarditis registry
  81. Normal Values of Three-Dimensional Right Ventricular Size and Function Measurements: Results of the World Alliance Societies of Echocardiography Study
  82. Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention
  83. Stress Echocardiography in Italian Echocardiographic Laboratories: A Survey of the Italian Society of Echocardiography and Cardiovascular Imaging
  84. Haemodynamic validation of the three‐step HFA‐PEFF algorithm to diagnose heart failure with preserved ejection fraction
  85. Use of artificial intelligence to automatically predict the optimal patient-specific inversion time for late gadolinium enhancement imaging. Tool development and clinical validation
  86. Changes in blood flow vortices inside the left ventricle in COVID-19 patients with intraventricular clot despite a normal coronary and myocardial motion
  87. Corrigendum to: Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry
  88. The MANTRA study: a new umbrella concept prospectively applied to assess implantable medical devices for heart valve procedures
  89. Pulmonary artery wedge pressure and left ventricular end-diastolic pressure during exercise in patients with dyspnoea
  90. Corrigendum: The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype
  91. Impact of severe secondary tricuspid regurgitation on rest and exercise hemodynamics of patients with heart failure and a preserved left ventricular ejection fraction
  92. Non-invasive evaluation of pulmonary capillary wedge pressure using the left atrial expansion index in mitral valve stenosis, prosthesis and repair
  93. Comparison of RA Volumes Obtained Using the Standard Apical 4-Chamber and the RV-Focused Views
  94. An accurate and time-efficient deep learning-based system for automated segmentation and reporting of cardiac magnetic resonance-detected ischemic scar
  95. The use of dedicated long-axis views focused on the left atrium improves the accuracy of left atrial volumes and emptying fraction measured by cardiovascular magnetic resonance
  96. Can three-dimensional echocardiography change the game for the pulmonary valve?
  97. Organization and Activity of Italian Echocardiographic Laboratories: A Survey of the Italian Society of Echocardiography and Cardiovascular Imaging
  98. Myocardial Fibrosis at Cardiac MRI Helps Predict Adverse Clinical Outcome in Patients with Mitral Valve Prolapse
  99. Association of outcome with left ventricular volumes and ejection fraction measured with two- and three-dimensional echocardiography in patients referred for routine, clinically indicated studies
  100. Left atrial volume and left ventricular mass for pulmonary capillary wedge pressure assessment with cardiovascular magnetic resonance: accurate enough for clinical use?
  101. The atrial secondary tricuspid regurgitation is associated to more favorable outcome than the ventricular phenotype
  102. Oxidative Stress in Structural Valve Deterioration: A Longitudinal Clinical Study
  103. An updated meta‐analysis of hemodynamics markers of prognosis in patients with pulmonary hypertension due to left heart disease
  104. Application of AI in cardiovascular multimodality imaging
  105. Feasibility and Time Analysis of Three-Dimensional and Myocardial Deformation versus Conventional Two-Dimensional Echocardiography to Assess Cardiac Chambers
  106. Reference ranges of tricuspid annulus geometry in healthy adults using a dedicated three-dimensional echocardiography software package
  107. EACVI survey on the multi-modality imaging assessment of the right heart
  108. Letter to the editor regarding ‘Cardiac magnetic resonance for prophylactic implantable-cardioverter defibrillator therapy international study: prognostic value of cardiac magnetic resonance-derived right ventricular parameters substudy’
  109. Correction to: Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry
  110. Exercise haemodynamics in heart failure with preserved ejection fraction: a systematic review and meta‐analysis
  111. Impact of correcting the 2D PISA method on the quantification of functional tricuspid regurgitation severity
  112. Prevalence of Structural Heart Diseases Detected by Handheld Echocardiographic Device in School-Age Children in Iran: The SHED LIGHT Study
  113. Outcomes of culture-negative vs. culture-positive infective endocarditis: the ESC-EORP EURO-ENDO registry
  114. Shedding new light on the fascinating right heart
  115. Characteristics, management, and outcomes of patients with left‐sided infective endocarditis complicated by heart failure: a substudy of the ESC‐EORP EURO‐ENDO (European infective endocarditis) registry
  116. Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC‐TIVE study, an Italian nationwide survey
  117. Shedding light on the pathophysiology of non-valvular atrial fibrillation as a primary cause of the regurgitation of atrio-ventricular valves
  118. Normal Values of Left Ventricular Size and Function on Three-Dimensional Echocardiography: Results of the World Alliance Societies of Echocardiography Study
  119. Multi-modality imaging assessment of native valvular regurgitation: an EACVI and ESC council of valvular heart disease position paper
  120. Surgery and outcome of infective endocarditis in octogenarians: prospective data from the ESC EORP EURO-ENDO registry
  121. Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis) registry
  122. Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome
  123. Novel Transcatheter Mitral Prosthesis Designed to Preserve Physiological Ventricular Flow Dynamics
  124. The role of antibody responses against glycans in bioprosthetic heart valve calcification and deterioration
  125. Atrial Functional Tricuspid Regurgitation as a Distinct Pathophysiological and Clinical Entity: No Idiopathic Tricuspid Regurgitation Anymore
  126. Effective Study: Development and Application of a Question‐Driven, Time‐Effective Cardiac Magnetic Resonance Scanning Protocol
  127. Evaluation of right ventricular function and pulmonary hypertension
  128. Challenges and future perspectives of transcatheter tricuspid valve interventions: adopt old strategies or adapt to new opportunities?
  129. Biomarkers Predict In-Hospital Major Adverse Cardiac Events in COVID-19 Patients: A Multicenter International Study
  130. Tricuspid regurgitation management: a systematic review of clinical practice guidelines and recommendations
  131. Left Atrial Expansion Index for Noninvasive Estimation of Pulmonary Capillary Wedge Pressure: A Cardiac Catheterization Validation Study
  132. 366 The use of dedicated long-axis views focused on the left atrium improves the accuracy of left atrial volumes and function measured by cardiovascular magnetic resonance
  133. Right heart chambers geometry and function in patients with the atrial and the ventricular phenotypes of functional tricuspid regurgitation
  134. Recent advances in multimodality imaging of the tricuspid valve
  135. Automated left atrial volume measurement by two-dimensional speckle-tracking echocardiography: feasibility, accuracy, and reproducibility
  136. Contraction Patterns of the Right Ventricle Associated with Different Degrees of Left Ventricular Systolic Dysfunction
  137. Normal Values of Cardiac Output and Stroke Volume According to Measurement Technique, Age, Sex, and Ethnicity: Results of the World Alliance of Societies of Echocardiography Study
  138. Lung Ultrasound in Patients With SARS‐COV‐2 Pneumonia: Correlations With Chest Computed Tomography, Respiratory Impairment, and Inflammatory Cascade
  139. A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization — the first insight from the AC-TIVE Study
  140. Diagnosis and Management of Aortic Valve Stenosis: The Role of Non-Invasive Imaging
  141. Use of the three-dimensional technique to remove the looking glass through which the echocardiographers have imagined the pathophysiology of atrioventricular valve regurgitation
  142. Global and regional right ventricular mechanics in repaired tetralogy of Fallot with chronic severe pulmonary regurgitation: a three-dimensional echocardiography study
  143. Multimodality cardiac imaging and new display options to broaden our understanding of the tricuspid valve
  144. Categorical Grading of the Severity of Tricuspid Regurgitation and its Association to Patients’ Outcome
  145. Dark blood ischemic LGE segmentation using a deep learning approach
  146. The Pathophysiological Link between Right Atrial Remodeling and Functional Tricuspid Regurgitation in Patients with Atrial Fibrillation: A Three-Dimensional Echocardiography Study
  147. Current Limitations of Invasive Exercise Hemodynamics for the Diagnosis of Heart Failure With Preserved Ejection Fraction
  148. Impact of COVID-19 on exercise pathophysiology: a combined cardiopulmonary and echocardiographic exercise study
  149. Atrial functional tricuspid regurgitation: a novel and underappreciated clinical entity
  150. Normal Values of Right Atrial Size and Function According to Age, Sex, and Ethnicity: Results of the World Alliance Societies of Echocardiography Study
  151. 3-D Echocardiography Is Feasible and More Reproducible than 2-D Echocardiography for In-Training Echocardiographers in Follow-up of Patients with Heart Failure with Reduced Ejection Fraction
  152. The Added Value of 3-Dimensional Echocardiography to Understand the Pathophysiology of Functional Tricuspid Regurgitation
  153. Systemic Sclerosis and Pulmonary Hypertension
  154. Ecocardiografia Tridimensional Revela o Verdadeiro Inimigo em um Jovem de Sexo Masculino com Infarto do Miocárdio com Supradesnivelamento do Segmento ST e Regurgitação Mitral Grave: “Pseudo-Fenda” Posterior e Prolapso da Valva Mitral
  155. Inter-vendor variability in strain measurements depends on software rather than image characteristics
  156. Artificial intelligence and the promise of uplifting echocardiography
  157. Regional shape, global function and mechanics in right ventricular volume and pressure overload conditions: a three-dimensional echocardiography study
  158. Disease Staging and Outcome in Pulmonary Hypertension
  159. Right atrial volume is a major determinant of tricuspid annulus area in functional tricuspid regurgitation: a three-dimensional echocardiographic study
  160. Haemodynamic characteristics of COVID‐19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization
  161. Echocardiographic assessment of the tricuspid and pulmonary valves: a practical guideline from the British Society of Echocardiography
  162. Prognostic validation of partition values for quantitative parameters to grade functional tricuspid regurgitation severity by conventional echocardiography
  163. Functional Tricuspid Regurgitation and Atrial Fibrillation: Which Comes First, the Chicken or the Egg?
  164. Left Ventricular Diastolic Function in Healthy Adult Individuals: Results of the World Alliance Societies of Echocardiography Normal Values Study
  165. The tale of functional tricuspid regurgitation: when atrial fibrillation is the villain
  166. Evaluation of Left Atrial Size and Function: Relevance for Clinical Practice
  167. The Importance and the Challenges of Predicting the Progression of Functional Tricuspid Regurgitation
  168. Relation of Mitral Annulus and Left Atrial Dysfunction to the Severity of Functional Mitral Regurgitation in Patients with Dilated Cardiomyopathy
  169. Advanced imaging of right ventricular anatomy and function
  170. Assessment of left ventricular diastolic function by three‐dimensional transthoracic echocardiography
  171. How to do LA strain
  172. How to do right ventricular strain
  173. Does atrial fibrillation affect the tricuspid annulus 3D geometry in patients without severe valve regurgitation?
  174. RIGHT VENTRICULAR GLOBAL LONGITUDINAL STRAIN PREDICTS CARDIOVASCULAR MORTALITY AND HEART FAILURE HOSPITALIZATION IN PATIENTS WITH FUNCTIONAL TRICUSPID REGURGITATION
  175. Echocardiographic reference ranges for normal left ventricular layer-specific strain: results from the EACVI NORRE study
  176. Author's Reply
  177. Do we need different threshold values to define normal left atrial size in different age groups? Another piece of the puzzle of left atrial remodelling with physiological ageing
  178. Functional Regurgitation of Atrioventricular Valves and Atrial Fibrillation: An Elusive Pathophysiological Link Deserving Further Attention
  179. Artificial Intelligence and Cardiovascular Imaging. A win-win Combination
  180. Principali applicazioni dell’ecocardiografia tridimensionale nell’attuale pratica clinica
  181. Three-dimensional echocardiography to assess left ventricular geometry and function
  182. Similarities and Differences in Left Ventricular Size and Function among Races and Nationalities: Results of the World Alliance Societies of Echocardiography Normal Values Study
  183. Prognostic value of right ventricular free wall longitudinal strain in a large cohort of outpatients with left-side heart disease
  184. Sequencing of NOTCH1 gene in an Italian population with bicuspid aortic valve: Preliminary results from the GISSI OUTLIERS VAR study
  185. Development and prognostic validation of partition values to grade right ventricular dysfunction severity using 3D echocardiography
  186. Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study
  187. Correlation between non-invasive myocardial work indices and main parameters of systolic and diastolic function: results from the EACVI NORRE study
  188. Relative Prognostic Importance of Left and Right Ventricular Ejection Fraction in Patients With Cardiac Diseases
  189. Impact of apical foreshortening on deformation measurements: a report from the EACVI-ASE Strain Standardization Task Force
  190. New Directions in Right Ventricular Assessment Using 3-Dimensional Echocardiography
  191. Measure the right parameters, set the right targets
  192. Left atrial function: an overlooked metrics in clinical routine echocardiography
  193. Layer-Specific Segmental Longitudinal Strain Measurements: Capability of Detecting Myocardial Scar and Differences in Feasibility, Accuracy, and Reproducibility, Among Four Vendors A Report From the EACVI-ASE Strain Standardization Task Force
  194. Correction
  195. Cohort profile The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry
  196. Left Atrial Structure and Function, and Left Ventricular Diastolic Dysfunction
  197. Morphological Assessment of the Tricuspid Apparatus and Grading Regurgitation Severity in Patients With Functional Tricuspid Regurgitation
  198. Twist Mechanics of the Left Ventricle
  199. Comparison Between Four-Chamber and Right Ventricular–Focused Views for the Quantitative Evaluation of Right Ventricular Size and Function
  200. 3-Dimensional Echocardiography in Imaging the Tricuspid Valve
  201. IMPROVING ARRHYTHMIC RISK STRATIFICATION AND IMPIANTABLE CARDIOVERTER DEFIBRILLATOR PATIENT SELECTION: A PROSPECTIC STUDY COMPARING OLD AND NEW ECHOCARDIOGRAPHY PARAMETERS
  202. ROLE OF NON-INVASIVE LEFT VENTRICULAR PRESSURE-STRAIN LOOP TO PREDICT CARDIAC DEATH AND ARRHYTHMIC RISK IN PATIENT WITH ORGANIC HEART DISEASE AND REDUCED LEFT VENTRICULAR EJECTION FRACTION
  203. First Clinical Experience With 3-Dimensional Echocardiographic Transillumination Rendering
  204. Transcatheter Tricuspid Valve Replacement
  205. Aortic Regurgitation
  206. Assessment After Surgery or Interventional Procedures on the Tricuspid Valve
  207. Functional Tricuspid Regurgitation
  208. How to Implement Three-Dimensional Echocardiography in the Routine of the Echocardiography Laboratory
  209. Organic Tricuspid Regurgitation
  210. Physics and Technical Principles of Three-Dimensional Echocardiography
  211. Routine Assessment of the Left Ventricle
  212. The Evolution of Three-Dimensional Echocardiography: From the Initial Concept to Real-Time Imaging
  213. The Normal Tricuspid Valve
  214. Textbook of Three-Dimensional Echocardiography
  215. Echocardiographic reference ranges for normal non-invasive myocardial work indices: results from the EACVI NORRE study
  216. An atypical case of pulmonary embolism from a jugular vein
  217. Comparison of mitral annulus geometry between patients with ischemic and non-ischemic functional mitral regurgitation: implications for transcatheter mitral valve implantation
  218. Fully Automatic Assessment of Mitral Valve Morphology from 3D Transthoracic Echocardiography
  219. Added Value of 3- Versus 2-Dimensional Echocardiography Left Ventricular Ejection Fraction to Predict Arrhythmic Risk in Patients With Left Ventricular Dysfunction
  220. Ventricular Arrhythmias in Young Competitive Athletes: Prevalence, Determinants, and Underlying Substrate
  221. Corrigendum
  222. Morphologic Analysis of the Normal Right Ventricle Using Three-Dimensional Echocardiography–Derived Curvature Indices
  223. Leveraging Mobile Technology to Reduce Resource-Related Health Care Disparities
  224. Physiological Determinants of Left Ventricular Mechanical Dispersion
  225. Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging
  226. EuroEcho-imaging 2017: highlights
  227. Comparison of Feasibility, Accuracy, and Reproducibility of Layer-Specific Global Longitudinal Strain Measurements Among Five Different Vendors: A Report from the EACVI-ASE Strain Standardization Task Force
  228. THREE-DIMENSIONAL ECHOCARDIOGRAPHY LEFT VENTRICULAR EJECTION FRACTION IMPROVES PATIENT SELECTION OF IMPLANTABLE CARDIOVERTER DEFIBRILLATORS OVER TWO-DIMENSIONAL EJECTION FRACTION
  229. Focus cardiac ultrasound core curriculum and core syllabus of the European Association of Cardiovascular Imaging
  230. Echocardiographic reference ranges for normal left atrial function parameters: results from the EACVI NORRE study
  231. Overview of mitral regurgitation in Europe: results from the European Registry of mitral regurgitation (EuMiClip)
  232. Intervendor Consistency and Accuracy of Left Ventricular Volume Measurements Using Three-Dimensional Echocardiography
  233. Three-dimensional speckle-tracking echocardiography: benefits and limitations of integrating myocardial mechanics with three-dimensional imaging
  234. Intervendor Differences in the Accuracy of Detecting Regional Functional Abnormalities
  235. Variability and Reproducibility of Segmental Longitudinal Strain Measurement
  236. Tricuspid Annulus Measurements: Dynamic Changes in Health and Disease
  237. 3-Dimensional Echocardiographic Analysis of the Tricuspid Annulus Provides New Insights Into Tricuspid Valve Geometry and Dynamics
  238. Clinical and Prognostic Implications of Methods and Partition Values Used to Assess Left Atrial Volume by Two-Dimensional Echocardiography
  239. Multimodality Imaging Assessment of Aortic Regurgitation
  240. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI)
  241. Impact of micro-scale heterogeneity on gas diffusivity of organic-rich shale matrix
  242. Pulmonary congestion evaluated by lung ultrasound predicts decompensation in heart failure outpatients
  243. The Good, the Bad, and the Ugly of Using Left Ventricular Longitudinal Myocardial Deformation by Speckle-Tracking Echocardiography to Assess Patients After an Acute Myocardial Infarction
  244. Echocardiographic reference ranges for normal left ventricular 2D strain: results from the EACVI NORRE study
  245. Left bundle branch block: from cardiac mechanics to clinical and diagnostic challenges
  246. EuroEcho-Imaging 2016: highlights
  247. Transthoracic 3D echocardiography imaging of transcatheter pacing system
  248. Quantification of the relative contribution of the different right ventricular wall motion components to right ventricular ejection fraction: the ReVISION method
  249. Bioinformatic Analysis of Glycoside Hydrolases in the Proteomes of Mesophilic and Thermophilic Actinobacteria
  250. Rational and design of EuroCRT: an international observational study on multi-modality imaging and cardiac resynchronization therapy
  251. Appropriateness criteria for the use of cardiovascular imaging in heart valve disease in adults: a European Association of Cardiovascular Imaging report of literature review and current practice
  252. Impact of Changes in Left Ventricular Ejection Fraction on Survival After Transapical Aortic Valve Implantation
  253. Assessment of left and right ventricular rotational interdependence: A speckle tracking echocardiographic study
  254. Comprehensive multi-modality imaging approach in arrhythmogenic cardiomyopathy—an expert consensus document of the European Association of Cardiovascular Imaging
  255. Echocardiographic follow-up after transcatheter aortic valve replacement
  256. Echocardiographic Techniques of Deformation Imaging in the Evaluation of Maternal Cardiovascular System in Patients with Complicated Pregnancies
  257. 3D printing of normal and pathologic tricuspid valves from transthoracic 3D echocardiography data sets
  258. 3D echocardiographic reference ranges for normal left ventricular volumes and strain: results from the EACVI NORRE study
  259. Effects of mitral valve repair on ventricular arrhythmia in patients with mitral valve prolapse syndrome: A report of two cases
  260. Multimodality imaging of pericardial diseases
  261. Physiologic Determinants of Left Atrial Longitudinal Strain: A Two-Dimensional Speckle-Tracking and Three-Dimensional Echocardiographic Study in Healthy Volunteers
  262. Current Clinical Applications of Three-Dimensional Echocardiography: When the Technique Makes the Difference
  263. Tricuspid regurgitation in a patient with ascending aorta aneurysm
  264. Criteria for recommendation and expert consensus papers: from the European Association of Cardiovascular Imaging Scientific Documents Committee
  265. The use of multimodality cardiovascular imaging to assess right ventricular size and function
  266. Left Atrial Volumes and Function by Three-Dimensional EchocardiographyCLINICAL PERSPECTIVE
  267. HIT initiative: discussion with the seniors
  268. 2015 ESC GUIDELINES FOR THE DIAGNOSIS AND MANAGEMENT OF PERICARDIAL DISEASES
  269. Subclinical Right Ventricular Dysfunction by Strain Analysis
  270. Whatʼs new in 2015 ESC guidelines on pericardial diseases?
  271. Two-dimensional transthoracic echocardiographic normal reference ranges for proximal aorta dimensions: results from the EACVI NORRE study
  272. Life-threatening ventricular tachyarrhythmias in the cardiology department: Implications for appropriate prescription of telemetry monitoring
  273. DYNAMIC RIGHT VENTRICULAR SHAPE ANALYSIS IN THE NORMAL HEART USING 3D ECHOCARDIOGRAPHY-DERIVED CURVATURE INDICES
  274. FEASIBILITY AND RELATIVE ACCURACY OF THREE-DIMENSIONAL PRINTING OF NORMAL AND PATHOLOGIC TRICUSPID VALVES FROM TRANSTHORACIC THREE-DIMENSIONAL ECHOCARDIOGRAPHIC DATA SETS
  275. THREE-DIMENSIONAL ECHOCARDIOGRAPHY ASSESSMENT OF THE SYSTOLIC VARIATION OF EFFECTIVE REGURGITANT ORIFICE AREA IN PATIENTS WITH FUNCTIONAL TRICUSPID REGURGITATION: IMPLICATIONS FOR QUANTIFICATION
  276. Guía ESC/ERS 2015 sobre diagnóstico y tratamiento de la hipertensión pulmonar
  277. Sex- and Method-Specific Reference Values for Right Ventricular Strain by 2-Dimensional Speckle-Tracking EchocardiographyCLINICAL PERSPECTIVE
  278. Relationship between mitral annulus function and mitral regurgitation severity and left atrial remodelling in patients with primary mitral regurgitation
  279. OUP accepted manuscript
  280. The Imaging of Right Ventricular Dysfunction in Heart Failure
  281. Revisit of Functional Tricuspid Regurgitation; Current Trends in the Diagnosis and Management
  282. OUP accepted manuscript
  283. Tricuspid Regurgitation
  284. Physics and Instrumentation
  285. Young community of EACVI: the transition from EACVI Club 35 to Heart Imagers of Tomorrow: a promising yet challenging step
  286. New speckle-tracking algorithm for right ventricular volume analysis from three-dimensional echocardiographic data sets: validation with cardiac magnetic resonance and comparison with the previous analysis tool
  287. Wytyczne ESC dotyczące rozpoznawania i leczenia chorób osierdzia w 2015 roku
  288. 2015 ESC Guidelines for the Diagnosis and Management of Pericardial Diseases
  289. Artículo especial Guía ESC 2015 sobre el diagnóstico y tratamiento de las enfermedades del pericardio
  290. Linee guida ESC 2015 per la diagnosi e il trattamento delle malattie del pericardio. Task Force per la Diagnosi e il Trattamento delle Malattie del Pericardio della Società Europea di Cardiologia (ESC)
  291. Head-to-Head Comparison of Global Longitudinal Strain Measurements among Nine Different Vendors
  292. Eight years of the EACVI's grant programme: existing developments, impact, and steps forward: Table 1
  293. Fully Automated Versus Standard Tracking of Left Ventricular Ejection Fraction and Longitudinal Strain
  294. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
  295. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases
  296. Left ventricular pseudoaneurysm after transapical aortic valve-in-valve implantation: use of transthoracic 3D echocardiography for guiding therapeutic approach
  297. Two-dimensional speckle tracking echocardiography: standardization efforts based on synthetic ultrasound data
  298. Saturday, 29 August 2015
  299. Sunday, 30 August 2015
  300. Monday, 31 August 2015
  301. Club 35 EACVI web spotlight: comments on right ventricle assessment in the new echocardiography recommendations
  302. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation
  303. Variability of Tricuspid Annulus Diameter Measurement in Healthy Volunteers
  304. Ethnic-Specific Normative Reference Values for Echocardiographic LA and LV Size, LV Mass, and Systolic Function
  305. Left ventricular shape and mass impact torsional dynamics in asymptomatic patients with chronic aortic regurgitation and normal left ventricular ejection fraction
  306. Cleft-like indentations in myxomatous mitral valves by three-dimensional echocardiographic imaging
  307. Transthoracic three-dimensional echocardiography visualization of functional anatomy of double-orifice mitral valve:
  308. Echocardiographic reference ranges for normal cardiac Doppler data: results from the NORRE Study
  309. Evaluation of right ventricular function performed by 3d-echocardiography in scleroderma patients
  310. THE SEVERITY OF FUNCTIONAL MITRAL REGURGITATION ASSESSED BY THREE-DIMENSIONAL ECHOCARDIOGRAPHY: NEW CUT-OFFS ARE NEEDED
  311. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
  312. Definitions for a Common Standard for 2D Speckle Tracking Echocardiography: Consensus Document of the EACVI/ASE/Industry Task Force to Standardize Deformation Imaging
  313. Dynamic Changes in Tricuspid Annular Diameter Measurement in Relation to the Echocardiographic View and Timing during the Cardiac Cycle
  314. Multimodality Imaging of Diseases of the Thoracic Aorta in Adults: From the American Society of Echocardiography and the European Association of Cardiovascular Imaging
  315. Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
  316. Standardized Myocardial Segmentation of the Left Ventricle
  317. Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging
  318. Laser heater commissioning at an externally seeded free-electron laser
  319. Non-invasive cardiac imaging evaluation of patients with chronic systolic heart failure: a report from the European Association of Cardiovascular Imaging (EACVI)
  320. Updated standards and processes for accreditation of echocardiographic laboratories from The European Association of Cardiovascular Imaging: an executive summary
  321. Normal mitral annulus dynamics and its relationships with left ventricular and left atrial function
  322. Quantitative Analysis of the Left Ventricle by Echocardiography in Daily Practice: As Simple as Possible, but Not Simpler
  323. J.R.T.C. ROELANDT (November 12, 1938-August 31, 2014)
  324. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
  325. Right Ventricular Geometry and Function in Pulmonary Hypertension: Non-Invasive Evaluation
  326. Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
  327. Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis
  328. Quantitative Analysis of Mitral Annular Geometry and Function in Healthy Volunteers Using Transthoracic Three-Dimensional Echocardiography
  329. Left Ventricular Myocardial Strain by Three-Dimensional Speckle-Tracking Echocardiography in Healthy Subjects: Reference Values and Analysis of Their Physiologic and Technical Determinants
  330. Normal Left Ventricular Mechanics by Two-dimensional Speckle-tracking Echocardiography. Reference Values in Healthy Adults
  331. Mecánica ventricular izquierda normal mediante ecocardiografía speckle tracking bidimensional. Valores de referencia para adultos sanos
  332. One‐and‐a‐Half Ventricle Repair as a Surgical Alternative to Fontan Revision in an Adult
  333. Triage strategy for urgent management of cardiac tamponade: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
  334. STAP cells can not be replicated
  335. CardioPulse Articles
  336. LEFT VENTRICULAR MYOCARDIAL STRAIN BY THREE-DIMENSIONAL SPECKLE-TRACKING ECHOCARDIOGRAPHY IN HEALTHY VOLUNTEERS: A NORMATIVE STUDY
  337. MITRAL VALVE LEAFLET ABNORMALITIES CORRELATE WITH LEFT VENTRICULAR REMODELLING AND OBSTRUCTION IN HYPERTROPHIC CARDIOMYOPATHY: A QUANTITATIVE 3D TRANSTHORACIC ECHOCARDIOGRAPHIC STUDY
  338. QUANTITATIVE ANALYSIS OF THE MITRAL ANNULUS GEOMETRY AND FUNCTION IN HEALTHY VOLUNTEERS: A TRANSTHORACIC THREE-DIMENSIONAL ECHOCARDIOGRAPHY STUDY
  339. REFERENCE VALUES OF TRICUSPID ANNULUS SIZE AND DYNAMICS BY TWO-DIMENSIONAL TRANSTHORACIC ECHOCARDIOGRAPHY IN 220 HEALTHY VOLUNTEERS
  340. Role of Three-Dimensional Echocardiography in Structural Complications after Acute Myocardial Infarction
  341. Updated standards and processes for accreditation of echocardiographic laboratories from The European Association of Cardiovascular Imaging
  342. Appropriateness criteria for cardiovascular imaging use in clinical practice: a position statement of the ESC/EACVI taskforce
  343. The impact of high-normal blood pressure on left ventricular mechanics: a three-dimensional and speckle tracking echocardiography study
  344. Echocardiographic reference ranges for normal cardiac chamber size: results from the NORRE study
  345. The appropriate and justified use of medical radiation in cardiovascular imaging: a position document of the ESC Associations of Cardiovascular Imaging, Percutaneous Cardiovascular Interventions and Electrophysiology
  346. 2013 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy
  347. Ocena geometrii i czynności prawej komory przy użyciu nowoczesnych technik echokardiograficznych
  348. Isolated Anterior Mitral Valve Leaflet Cleft: 3D Transthoracic Echocardiography-Guided Surgical Strategy
  349. The Clinical Benefits of Adding a Third Dimension to Assess the Left Ventricle with Echocardiography
  350. Poster session Thursday 12 December - AM: 12/12/2013, 08:30-12:30 * Location: Poster area
  351. Club 35 Moderated Poster Session - Part B: 11/12/2013, 09:30-16:00 * Location: Moderated Poster area
  352. A meta-analysis of echocardiographic measurements of the left heart for the development of normative reference ranges in a large international cohort: the EchoNoRMAL study
  353. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography
  354. EACVI-ASE-industry initiative to standardize deformation imaging: a brief update from the co-chairs
  355. Role of electrocardiography and echocardiography in prevention and predicting outcome of subjects at increased risk of heart failure
  356. Ascending aorta diameters measured by echocardiography using both leading edge-to-leading edge and inner edge-to-inner edge conventions in healthy volunteers
  357. Abnormal left ventricular longitudinal function assessed by echocardiographic and tissue Doppler imaging is a powerful predictor of diastolic dysfunction in hypertensive patients: The SPHERE study
  358. Response to Letter to the Editor by Rui Baptista, M.D., Rogério Teixeira, M.D.
  359. Expert Consensus for Multi-Modality Imaging Evaluation of Cardiovascular Complications of Radiotherapy in Adults: A Report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography
  360. Radial function correlates with heart failure symptoms in hypertrophic cardiomyopathy with normal ejection fraction
  361. Pulmonary congestion evaluated by lung ultrasound predicts admission in patients with heart failure
  362. Right ventricular function by 3D-echocardiography and 2D-speckle tracking in scleroderma patients in absence of pulmonary hypertension
  363. Predictive value of 2D and 3D deformation imaging of immediate and mid-term myocardial contractile recovery after recanalized STEMI: comparison with delayed enhancement cardiac magnetic resonance
  364. Reference values of right ventricular longitudinal strain by speckle tracking echocardiography in 219 healthy volunteers
  365. Changes in mitral annulus and leaflets size are related to regurgitation severity in organic mitral regurgitation: a three-dimensional transthoracic study
  366. Three-dimensional changes in mitral valve annulus geometry in organic and functional mitral regurgitation: insights for mitral valve repair
  367. Quantitative analysis of mitral valve geometry by transthoracic three-dimensional echocardiography: accuracy, feasibility, reproducibility and reference values
  368. Allometric normative equations for 3D right ventricular size and function: development and validation with equations derived using cardiac magnetic resonance
  369. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults: a report from the European Association of Cardiovascular Imaging and the American Society of Echocardiography
  370. Age-, Body Size-, and Sex-Specific Reference Values for Right Ventricular Volumes and Ejection Fraction by Three-Dimensional Echocardiography: A Multicenter Echocardiographic Study in 507 Healthy Volunteers
  371. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
  372. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Associati...
  373. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging
  374. Comprehensive Analysis of Left Ventricular Geometry and Function by Three-Dimensional Echocardiography in Healthy Adults
  375. Defining Normative Values for 3D LV Volumes
  376. The unbearable futility of deriving the left atrial size from a single-linear dimension
  377. PREDICTIVE VALUE OF 2D AND 3D DEFORMATION PARAMETERS AND WALL MOTION SCORE TO IDENTIFY TRANSMURAL MYOCARDIAL NECROSIS IN STEMI PATIENTS: A COMPARATIVE STUDY AGAINST CMR
  378. REFERENCE VALUES FOR RIGHT VENTRICULAR GEOMETRY AND FUNCTION BY 3D ECHOCARDIOGRAPHY: A MULTICENTER STUDY OF 533 HEALTHY SUBJECTS
  379. RIGHT ATRIAL VOLUMES AND PHASIC FUNCTION BY 3D ECHOCARDIOGRAPHY IN HEALTHY SUBJECTS
  380. Linee guida per il trattamento delle valvulopatie (versione 2012). Task Force congiunta per il Trattamento delle Valvulopatie della Società Europea di Cardiologia (ESC) e dell’Associazione Europea di Chirurgia Cardiotoracica (EACTS)
  381. Right atrial size and function assessed with three-dimensional and speckle-tracking echocardiography in 200 healthy volunteers
  382. EuroEcho and other imaging modalities: highlights
  383. Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in systemic sclerosis: A multicenter study
  384. Mitral valve anatomy and function
  385. Practical recommendations on the use of echocardiography to assess pulmonary arterial hypertension - a Belgian expert consensus endorsed by the Working Group on Non-Invasive Cardiac Imaging
  386. Normal Reference Ranges for Echocardiography: rationale, study design, and methodology (NORRE Study)
  387. Research and Innovations Committee a new outlook for the European Association of Cardiovascular Imaging (EACVI)
  388. Assessment of functional tricuspid regurgitation
  389. 2013 European Association Cardiovascular Imaging Research Grants
  390. Guía de práctica clínica de la ESC para el manejo del infarto agudo de miocardio en pacientes con elevación del segmento ST
  391. La aurícula izquierda como entidad tridimensional dinámica: consecuencias para la evaluación ecocardiográfica
  392. Emergency echocardiography: the European Association of Cardiovascular Imaging recommendations
  393. Oral Abstract Sessions * Do we really need 3D echo to access heart valve?: 3D-TTE
  394. Poster session: Dobutamine stress echo
  395. Quantitation of cardiac chamber geometry and function using transthoracic three-dimensional echocardiography
  396. Diastolic Mitral Regurgitation in 2:1 Atrioventricular Block: Insight of the Diastolic Pressure
  397. Use of three-dimensional speckle tracking to assess left ventricular myocardial mechanics: inter-vendor consistency and reproducibility of strain measurements
  398. Three‐Dimensional Transesophageal Echocardiography of Aortic Atherosclerosis
  399. Ultrasound and radiology surrogate endpoints in pharmacological studies
  400. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
  401. Guidelines on the management of valvular heart disease (version 2012)
  402. European guidelines for management of people with STEMI heart attack
  403. Anatomy and Pathology of Right-Sided Atrioventricular and Semilunar Valves
  404. Mechanisms, Evaluation and Management of Tricuspid Regurgitation
  405. The prognostic impact of dynamic ventricular dyssynchrony in patients with idiopathic dilated cardiomyopathy and narrow QRS
  406. Relations between professional medical associations and healthcare industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology
  407. Relations between professional medical associations and healthcare industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology
  408. Incremental value of three-dimensional strain imaging in Danon disease
  409. Towards an Integrated Echocardiographic Assessment of Valvular Mechanics by Three-Dimensional Volumetric Imaging
  410. Assessment of aortic valve complex by three-dimensional echocardiography: a framework for its effective application in clinical practice
  411. Relations between professional medical associations and the health-care industry, concerning scientific communication and continuing medical education: a Policy Statement from the European Society of Cardiology
  412. EuroEcho and other imaging modalities: highlights
  413. S.5.1 Clinical and echocardiographic correlations of exercise-induced pulmonary hypertension in SSc: a multicentre study
  414. EAE/ASE Recommendations for Image Acquisition and Display Using Three-Dimensional Echocardiography
  415. Current Clinical Applications of Transthoracic Three-Dimensional Echocardiography
  416. EAE/ASE Recommendations for Image Acquisition and Display Using Three-Dimensional Echocardiography
  417. European Association of Echocardiography: Research Grant Programme
  418. Sources of variation and bias in assessing left ventricular volumes and dyssynchrony using three-dimensional echocardiography
  419. Carcinoid tricuspid valve disease: incremental value of three-dimensional echocardiography
  420. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease
  421. EAE/ASE Recommendations for the Use of Echocardiography in New Transcatheter Interventions for Valvular Heart Disease
  422. Methodological approach for the assessment of ultrasound reproducibility of cardiac structure and function: a proposal of the study group of Echocardiography of the Italian Society of Cardiology (Ultra Cardia SIC) Part I
  423. EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease
  424. The Prognostic Value of Early Left Ventricular Longitudinal Systolic Dysfunction in Asymptomatic Subjects With Cardiovascular Risk Factors
  425. Influence of Noninvasive Cardiovascular Imaging in Primary Prevention
  426. Three-dimensional imaging of anomalous origin of the right coronary artery in a young athlete
  427. Recommendations of the European Association of Echocardiography How to use echo-Doppler in clinical trials: different modalities for different purposes
  428. Heart failure with preserved ejection fraction: A precursor of heart failure with reduced ejection fraction or a distinct syndrome?
  429. A large penetrating atherosclerotic ulcer of the ascending aorta
  430. Evaluation of Tricuspid Valve Morphology and Function by Transthoracic Three-Dimensional Echocardiography
  431. Current and Evolving Echocardiographic Techniques for the Quantitative Evaluation of Cardiac Mechanics: ASE/EAE Consensus Statement on Methodology and Indications Endorsed by the Japanese Society of Echocardiography
  432. Recommendations for transoesophageal echocardiography: update 2010
  433. Current and Evolving Echocardiographic Techniques for the Quantitative Evaluation of Cardiac Mechanics: ASE/EAE Consensus Statement on Methodology and Indications
  434. Early Left Ventricular Longitudinal Systolic Dysfunction and Cardiovascular Risk Factors in 1,371 Asymptomatic Subjects with Normal Ejection Fraction: A Tissue Doppler Study
  435. CardioPulse Articles
  436. The use of pocket-size imaging devices: a position statement of the European Association of Echocardiography
  437. Usefulness of Contrast Stress-Echocardiography or Exercise-Electrocardiography to Predict Long-Term Acute Coronary Syndromes in Patients Presenting With Chest Pain Without Electrocardiographic Abnormalities or 12-Hour Troponin Elevation
  438. Speckle-Tracking Echocardiography
  439. Textbook of Real-Time Three Dimensional Echocardiography
  440. Ecocardiografia multiplanare in tempo reale. Applicazioni attuali, limiti e prospettive
  441. 3-Dimensional Transesophageal Echocardiographic Assessment of Papillary Muscle Rupture Complicating Acute Myocardial Infarction
  442. The Incremental Prognostic Value of Echocardiography in Asymptomatic Stage A Heart Failure
  443. Left Atrial Dysfunction as a Correlate of Heart Failure Symptoms in Hypertrophic Cardiomyopathy
  444. Recommendations for transoesophageal echocardiography: update 2010
  445. Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance
  446. Valutazione della morfologia e della funzione della valvola tricuspide con ecocardiografia transtoracica tridimensionale in tempo reale
  447. Ecocardiografia tridimensionale transtoracica in tempo reale. Applicazioni, vantaggi e limiti per lo studio delle valvulopatie
  448. High Volume-Rate Three-Dimensional Stress Echocardiography to Assess Inducible Myocardial Ischemia: A Feasibility Study
  449. Real-Time Three Dimensional Echocardiography in the Postoperative Follow-Up of Type-A Aortic Dissection—A Case Report
  450. Multiple Intracardiac Sewing Needles in a Schizophrenic Woman With Self-Injurious Behavior
  451. Stenosi aortica critica asintomatica: chirurgia urgente o follow-up clinico? Sia pur bassa, la mortalità operatoria nel paziente con stenosi aortica asintomatica non è l'unico endpoint che orienta il clinico coscienzioso alla scelta medica
  452. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)
  453. Validation of an echo-Doppler decision model to predict left ventricular filling pressure in patients with heart failure independently of ejection fraction
  454. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease)
  455. Recommendations for the practice of echocardiography in infective endocarditis
  456. Mid-term clinical outcomes in cardiac surgery of Jehovahʼs witnesses
  457. Real-time three dimensional transesophageal echocardiography: technical aspects and clinical applications
  458. Left ventricular torsional dynamics in aortic stenosis: relationship between left ventricular untwisting and filling pressures. A two-dimensional speckle tracking study
  459. Validation of a novel automated border-detection algorithm for rapid and accurate quantitation of left ventricular volumes based on three-dimensional echocardiography
  460. Spiers Memorial Lecture : Interplay of theory and computation in chemistry—examples from on-water organic catalysis, enzyme catalysis, and single-molecule fluctuations
  461. Assessment of Tricuspid Valve Morphology and Function
  462. Future Developments of Three-Dimensional Echocardiography
  463. Role of Three-Dimensional Echocardiography in Drug Trials
  464. Three-Dimensional Echocardiography in Clinical Practice
  465. Heart Valve Prostheses
  466. New Developments in Echocardiography
  467. Head-to-head comparison of real-time three-dimensional transthoracic echocardiography with transthoracic and transesophageal two-dimensional contrast echocardiography for the detection of patent foramen ovale
  468. European Association of Echocardiography recommendations for training, competence, and quality improvement in echocardiography
  469. Population-Based Surveillance of Infectious Endocarditis in an Italian Region
  470. Right ventricle in pulmonary arterial hypertension: haemodynamics, structural changes, imaging, and proposal of a study protocol aimed to assess remodelling and treatment effects
  471. Left ventricular remodelling and torsional dynamics in dilated cardiomyopathy: reversed apical rotation as a marker of disease severity
  472. Laparoscopic approach for urgent abdominal surgery in patients with left ventricular assist devices
  473. Design and simulation challenges for FERMI@elettra
  474. 005 POPULATION BASED SURVEILLANCE OF INFECTIOUS ENDOCARDITIS IN A NORTH EST ITALIAN REGION
  475. Evaluation of the tricuspid valve morphology and function by transthoracic real-time three-dimensional echocardiography
  476. Contrast enhanced real-time three-dimensional echocardiography for quantification of myocardial perfusion: a step forward
  477. Effect on Quality of Life of Different Accelerated Diagnostic Protocols for Management of Patients Presenting to the Emergency Department With Acute Chest Pain
  478. Improved workflow, sonographer productivity, and cost-effectiveness of echocardiographic service for inpatients by using miniaturized systems
  479. Fast Data Acquisition and Analysis with Real Time Triplane Echocardiography for the Assessment of Left Ventricular Size and Function: A Validation Study
  480. L'ecocardiografia nel paziente iperteso
  481. Transient left ventricular apical ballooning syndrome: a 4-year experience
  482. Long-term survival of patients with congestive heart failure and preserved left ventricular ejection fraction: 9 years of follow-up
  483. How many patients would be misclassified using M-mode and two-dimensional estimates of left atrial size instead of left atrial volume? A three-dimensional echocardiographic study
  484. Congenital quadricuspid aortic valve associated with obstructive hypertrophic cardiomyopathy
  485. European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies
  486. American College of Cardiology/American Heart Association perioperative assessment guidelines for noncardiac surgery reduces cardiologic resource utilization preserving a favourable clinical outcome
  487. Comparison of Early Dobutamine Stress Echocardiography and Exercise Electrocardiographic Testing for Management of Patients Presenting to the Emergency Department With Chest Pain
  488. Pulmonary embolism and fever: an indication for urgent echocardiography not reported in clinical guidelines?
  489. Limited Long-Term Durability of the Cryolife O'Brien Stentless Porcine Xenograft Valve
  490. Unusual extension of an intracardiac primary lymphoma to the right jugular vein
  491. Severe Tricuspid Regurgitation Due to Entrapment of the Anterior Leaflet of the Valve by a Permanent Pacemaker Lead: Role of Real Time Three-Dimensional Echocardiography
  492. Left ventricular electromechanical delay in patients with heart failure and normal QRS duration and in patients with right and left bundle branch block
  493. Infective endocarditis in chronic haemodialysis patients: an increasing clinical challenge
  494. Fibrillazione atriale permanente e scompenso cardiaco: ablazione a radiofrequenza della giunzione atrioventricolare e terapia di resincronizzazione cardiaca. Revisione della letteratura e delle nuove tecniche di valutazione ecocardiografica
  495. Real-time three-dimensional echocardiography: technological gadget or clinical tool?
  496. Pulmonary Embolism and Fever: When Should Right-Sided Infective Endocarditis Be Considered?
  497. Left ventricular electromechanical delay in patients with heart failure and normal QRS duration and in patients with right and left bundle branch block
  498. Linac upgrading program for the FERMI project: Status and perspectives
  499. The new photoinjector for the FERMI project
  500. Results of Aortic Valve Replacement With a New Supra-Annular Pericardial Stented Bioprosthesis
  501. I tecnici di ecocardiografia: una realtà dei soli paesi anglosassoni? L'esperienza di un laboratorio italiano in cui sono attivi dal 1984
  502. Successful treatment of polymicrobial multivalve infective endocarditis
  503. Ruolo dell'ecocardiografia nella selezione dei pazienti da candidare alla terapia di resincronizzazione ventricolare
  504. Anomalous origin of the right coronary artery mimicking aortic dissection at transesophageal echocardiography
  505. Heart Failure and Severe Pulmonary Hypertension Caused by Distal Detachment of the Valve Conduit 16 Years After the Cabrol Composite Graft Procedure
  506. Clinical and hemodynamic implications of supra-annular implant of biological aortic valves
  507. Effects of Right Ventricular Pacing on Intra-Left Ventricular Electromechanical Activation in Patients With Native Narrow QRS
  508. Improved delineation of morphological features of arrhythmogenic right ventricular cardiomyopathy with the use of contrast-enhanced echocardiography
  509. Estimation of infarct size by single measurements of creatine kinase levels in patients with a first myocardial infarction
  510. The SUCIMA project: A status report on high granularity dosimetry and proton beam monitoring
  511. Additive value of contrast echocardiography for the diagnosis of noncompaction of the left ventricular myocardium
  512. Silicon Ultra fast Cameras for electron and γ sources In Medical Applications: a progress report
  513. Laboratory and in-beam tests of a novel real-time beam monitor for hadrontherapy
  514. Quantification methods in contrast echocardiography
  515. Heart-touching Chilaiditi’s syndrome
  516. Secondary emission monitor for low-interception monitoring (SLIM): an innovative nondestructive beam monitor for the extraction lines of a hadrontherapy center
  517. Report on the first written exam held as part of the European Association of Echocardiography Accreditation Process in Adult Transthoracic Echocardiography
  518. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction
  519. Position-sensitive silicon detectors for real-time dosimetry in medical applications
  520. Silicon ultra fast cameras for electron and γ sources in medical applications
  521. Acute Thrombosis of Mechanical Mitral Valve Prosthesis: Echo-Doppler Diagnosis and Successful Treatment with Systemic Thrombolysis
  522. Contrast echocardiographic evaluation of early changes in myocardial perfusion after recanalization therapy in anterior wall acute myocardial infarction and their relation with early contractile recovery
  523. SLIM (Secondary emission monitor for Low Interception Monitoring) an innovative non-destructive beam monitor for the extraction lines of a hadrontherapy center
  524. SUCIMA - Silicon Ultra fast Cameras for electron and gamma sources in Medical Applications
  525. ST segment monitoring of coronary reperfusion
  526. Relation between early mitral regurgitation and left ventricular thrombus formation after acute myocardial infarction: results of the GISSI-3 echo substudy
  527. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated diastolic dysfunction
  528. Comparison of early dobutamine stress echocardiography, exercise treadmill testing, and hospital admission for management of patients presenting to the emergency department with chest pain: a multicenter international randomized study
  529. The Italian national registry of coronary care units: initial results from an internet based, patient-care oriented data management tool
  530. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction
  531. Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure. The OSCUR study
  532. Heterogeneity of left ventricular remodeling after acute myocardial infarction: Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico-3 Echo Substudy
  533. Intravenous NPA for the treatment of infarcting myocardium early. InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction
  534. Electrocardiographic evolutionary changes and left ventricular remodeling after acute myocardial infarction11The Investigators and Institutions participating in the GISSI-3 Echo Substudy are listed in the Appendix.
  535. Use of a Common Computerized Program for Echocardiogram Archiving and Reporting Over a Regional Territory: Feasibility and Clinical and Research Impact During a 5-Year Experience
  536. Synchrotrons for hadron therapy: Part I
  537. Prevalence of microembolic signals in patients with different types of mono-leaflet and bi-leaflet prosthetic heart valves
  538. Normal echocardiographic characteristics of the sorin bicarbon bileaflet prosthetic heart valve in the mitral and aortic positions
  539. Changes in effective aortic valve area during ejection in adults with aortic stenosis
  540. Reproducibility of wall motion score and its correlation with left ventricular ejection fraction in patients with acute myocardial infarction
  541. Relation of right ventricular morphology and function in pectus excavatum to the severity of the chest wall deformity
  542. Recombinant Tissue Plasminogen Activator for Prosthetic Mitral-Valve Thrombosis
  543. The Italian project for a hadrontherapy centre
  544. Relation between ECG strain pattern and left ventricular morphology, left ventricular function, and DPTI/SPTI ratio in patients with aortic regurgitation
  545. Doppler haemodynamic assessment of clinically and echocardiographically normal mitral and aortic Allcarbon valve prostheses
  546. A Large Left Ventricular Thrombus Evolving Towards Canalization and Mimicking a Left Ventricular Pseudoaneurysm: An Echocardiographic Study
  547. Left ventricular myocardial function in myotonic dystrophy
  548. Infective right atrial thrombus: a rare complication of total parenteral nutrition in an adult
  549. Measurement of spin motions in a storage ring outside the stable polarization direction
  550. Measurement of spin motions in a storage ring outside the stable polarization direction